NO20052699D0 - 4(fenylpiperazinyl-metyl)benzamid-derivater og deres anvendelse ved behandling av smerte og gastrointestinale lidelser. - Google Patents

4(fenylpiperazinyl-metyl)benzamid-derivater og deres anvendelse ved behandling av smerte og gastrointestinale lidelser.

Info

Publication number: NO20052699D0
Authority: NO; Norway
Prior art keywords: phenylpiperazinylmethyl; pain; treatment; gastrointestinal disorders; benzamide derivatives
Prior art date: 2002-11-07

Application number

NO20052699A

Other languages

English (en)

Other versions

NO20052699L (no

Inventor

William Brown

Christopher Walpole

Andrew Griffin

Niklas Plobeck

Original Assignee

Astrazeneca Ab

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2002-11-07

Filing date

2005-06-06

Publication date

2005-06-06

2005-06-06 Application filed by Astrazeneca Ab filed Critical Astrazeneca Ab

2005-06-06 Publication of NO20052699D0 publication Critical patent/NO20052699D0/no

2005-06-06 Publication of NO20052699L publication Critical patent/NO20052699L/no

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
- C07D295/04—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms
- C07D295/14—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
- C07D295/155—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals with the ring nitrogen atoms and the carbon atoms with three bonds to hetero atoms separated by carbocyclic rings or by carbon chains interrupted by carbocyclic rings
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/10—Laxatives
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/12—Antidiarrhoeals
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/14—Antitussive agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/04—Drugs for skeletal disorders for non-specific disorders of the connective tissue
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P23/00—Anaesthetics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A61P25/16—Anti-Parkinson drugs
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/22—Anxiolytics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
- A61P25/32—Alcohol-abuse
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
- A61P25/34—Tobacco-abuse
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
- A61P25/36—Opioid-abuse
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
- A61P29/02—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID] without antiinflammatory effect
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/08—Antiallergic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
- C07D307/02—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings
- C07D307/34—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
- C07D307/38—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with substituted hydrocarbon radicals attached to ring carbon atoms
- C07D307/52—Radicals substituted by nitrogen atoms not forming part of a nitro radical

Landscapes

Health & Medical Sciences (AREA)
Organic Chemistry (AREA)
Chemical & Material Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Engineering & Computer Science (AREA)
General Chemical & Material Sciences (AREA)
General Health & Medical Sciences (AREA)
Pharmacology & Pharmacy (AREA)
Medicinal Chemistry (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Animal Behavior & Ethology (AREA)
Veterinary Medicine (AREA)
Bioinformatics & Cheminformatics (AREA)
Public Health (AREA)
Chemical Kinetics & Catalysis (AREA)
Biomedical Technology (AREA)
Neurosurgery (AREA)
Neurology (AREA)
Immunology (AREA)
Addiction (AREA)
Psychiatry (AREA)
Pulmonology (AREA)
Pain & Pain Management (AREA)
Rheumatology (AREA)
Urology & Nephrology (AREA)
Physical Education & Sports Medicine (AREA)
Cardiology (AREA)
Heart & Thoracic Surgery (AREA)
Orthopedic Medicine & Surgery (AREA)
Communicable Diseases (AREA)
Transplantation (AREA)
Vascular Medicine (AREA)
Hospice & Palliative Care (AREA)
Virology (AREA)
Oncology (AREA)
Psychology (AREA)
Endocrinology (AREA)
Reproductive Health (AREA)
Anesthesiology (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

NO20052699A 2002-11-07 2005-06-06 4(fenylpiperazinyl-metyl)benzamid-derivater og deres anvendelse ved behandling av smerte og gastrointestinale lidelser. NO20052699L (no)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
SE0203300A SE0203300D0 (sv)	2002-11-07	2002-11-07	Novel Compounds
PCT/SE2003/001703 WO2004041800A1 (en)	2002-11-07	2003-11-05	4(phenyl-piperazinyl-methyl) benzamide derivatives and their use for the treatment of pain or gastrointestinal disorders

Publications (2)

Publication Number	Publication Date
NO20052699D0 true NO20052699D0 (no)	2005-06-06
NO20052699L NO20052699L (no)	2005-06-06

Family

ID=20289504

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
NO20052699A NO20052699L (no)	2002-11-07	2005-06-06	4(fenylpiperazinyl-metyl)benzamid-derivater og deres anvendelse ved behandling av smerte og gastrointestinale lidelser.

Country Status (20)

Country	Link
US (1)	US7396834B2 (no)
EP (1)	EP1562922A1 (no)
JP (1)	JP2006507296A (no)
KR (1)	KR20050072794A (no)
CN (1)	CN100471844C (no)
AR (1)	AR041898A1 (no)
AU (1)	AU2003274884B2 (no)
BR (1)	BR0315998A (no)
CA (1)	CA2502733A1 (no)
IS (1)	IS7864A (no)
MX (1)	MXPA05004709A (no)
NO (1)	NO20052699L (no)
NZ (1)	NZ539483A (no)
PL (1)	PL376895A1 (no)
RU (1)	RU2326875C2 (no)
SE (1)	SE0203300D0 (no)
TW (1)	TW200418823A (no)
UA (1)	UA79824C2 (no)
WO (1)	WO2004041800A1 (no)
ZA (1)	ZA200503553B (no)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
AR035974A1 (es) *	2001-05-18	2004-07-28	Astrazeneca Ab	Derivados de diarilmetil piperazina, procesos para su preparacion, uso de estos derivados para la elaboracion de medicamentos y composicion farmaceutica
SE0203302D0 (sv)	2002-11-07	2002-11-07	Astrazeneca Ab	Novel Compounds
SE0203303D0 (sv) *	2002-11-07	2002-11-07	Astrazeneca Ab	Novel Compounds
SE0203300D0 (sv)	2002-11-07	2002-11-07	Astrazeneca Ab	Novel Compounds
EP1675847B1 (en)	2003-10-01	2012-12-05	Adolor Corporation	Spirocyclic heterocyclic derivatives and methods of their use
SE0401968D0 (sv) *	2004-08-02	2004-08-02	Astrazeneca Ab	Diarylmethyl piperazine derivatives, preparations thereof and uses thereof
HRP20120343T1 (hr) *	2004-08-02	2012-05-31	Astrazeneca Ab	Derivati diarilmetil piperazina, njihovi pripravci i njihova uporaba
US20080262229A1 (en) *	2005-02-28	2008-10-23	Astrazeneca Ab	Diarylmethyl Piperazine Derivatives, Preparations Thereof and Uses Thereof
US7598261B2 (en)	2005-03-31	2009-10-06	Adolor Corporation	Spirocyclic heterocyclic derivatives and methods of their use
US7576207B2 (en)	2006-04-06	2009-08-18	Adolor Corporation	Spirocyclic heterocyclic derivatives and methods of their use
ES2283220B1 (es) *	2006-04-12	2008-11-01	Consejo Superior Investig. Cientificas	Uso de agonistas del receptor opioide delta en la elaboracion de composiciones farmaceuticas, composiciones farmaceuticas que las contienen y sus aplicaciones en el tratamiento de tumores.
EP2296657A4 (en) *	2008-05-20	2011-12-14	Astrazeneca Ab	METHOD FOR TREATING HEAVY DEPRESSION WITH FEARING STATES
RU2505536C1 (ru) *	2012-12-29	2014-01-27	Федеральное государственное бюджетное образовательное учреждение высшего профессионального образования "Ярославский государственный технический университет"	4-(1-гидрокси-1-метил-2-морфолиноэтил)бензойная и 4-(1-гидрокси-2-морфолиноциклогексил)бензойная кислоты, их фармацевтически приемлемые соли, сложные эфиры, обладающие анксиолитической активностью, и способ их получения

Family Cites Families (43)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
CH585209A5 (no)	1973-06-29	1977-02-28	Cermol Sa
DE2900810A1 (de)	1979-01-11	1980-07-24	Cassella Ag	Substituierte n-benzhydryl-n'-p- hydroxybenzyl-piperazine und verfahren zu ihrer herstellung
IT1140978B (it)	1980-05-23	1986-10-10	Selvi & C Spa	1-(4-clorobenzidril)-4-(2,3-diidros sipropil)-piperazina, metodi per la sua preparazione e relative composizione farmaceutiche
GB8320701D0 (en)	1983-08-01	1983-09-01	Wellcome Found	Chemotherapeutic agent
IT1196150B (it)	1984-06-19	1988-11-10	Poli Ind Chimica Spa	Derivati di 1-(bis-(4-fluorofenil)metil)-4-(3-fenil-2-propenil)-esaidro-1h-1,4-diazepina ad attivita' calcio antagonista,sua preparazione e composizioni che lo contengono
SE8500573D0 (sv) *	1985-02-08	1985-02-08	Ferrosan Ab	Novel piperazinecarboxamides having a phenoxyalkyl or thiophenoxyalkyl side chain
US5028610A (en)	1987-03-18	1991-07-02	Sankyo Company Limited	N-benzhydryl-substituted heterocyclic derivatives, their preparation and their use
US4829065A (en)	1987-04-24	1989-05-09	Syntex Pharmaceuticals, Ltd.	Substituted imidazolyl-alkyl-piperazine and -diazepine derivatives
US4826844A (en)	1987-09-30	1989-05-02	American Home Products Corporation	Substituted 1-(aralkyl-piperazinoalkyl) cycloalkanols
US5840896A (en) *	1989-11-22	1998-11-24	Janssen Pharmaceutica, N.V.	Method of preventing or limiting reperfusion damage
ES2053208T3 (es)	1989-11-22	1994-07-16	Janssen Pharmaceutica Nv	Metodo para prevenir o limitar el daño por reperfusion.
EP0546102B1 (en)	1990-08-29	1997-10-15	PHARMACIA & UPJOHN COMPANY	Tropolone derivatives and pharmaceutical composition thereof for preventing and treating ischemic diseases
FI931600A7 (fi)	1990-10-10	1993-05-17	Schering Corp	Diaryylimetyylipiperidiinien tai piperatsiinien pyridiinit ja pyridiin i-N-oksidijohdokset, ja yhdisteet ja menetelmät niiden käyttämiseksi
GB9202238D0 (en)	1992-02-03	1992-03-18	Wellcome Found	Compounds
US5807858A (en)	1996-06-05	1998-09-15	Delta Pharmaceutical, Inc.	Compositions and methods for reducing respiratory depression
US5574159A (en)	1992-02-03	1996-11-12	Delta Pharmaceuticals, Inc.	Opioid compounds and methods for making therefor
US5681830A (en)	1992-02-03	1997-10-28	Delta Pharmaceuticals, Inc.	Opioid compounds
FR2696744B1 (fr)	1992-10-12	1994-12-30	Logeais Labor Jacques	Dérivés de 2-pyrrolidone, leur procédé de préparation et leurs applications en thérapeutique.
RU2124511C1 (ru)	1993-05-14	1999-01-10	Фармасьютикал Ко., Лтд	Производные пиперазина
IL110512A (en)	1993-07-30	1998-10-30	Delta Pharmaceuticals Inc	History of diarylmethyl piperazine, their preparation and pharmaceutical preparations containing them
JP3352184B2 (ja)	1993-11-12	2002-12-03	株式会社アズウェル	ピペラジン不飽和脂肪酸誘導体
IL117149A0 (en)	1995-02-23	1996-06-18	Schering Corp	Muscarinic antagonists
SE9504661D0 (sv) *	1995-12-22	1995-12-22	Astra Pharma Inc	New compounds
TW548271B (en)	1996-12-20	2003-08-21	Astra Pharma Inc	Novel piperidine derivatives having an exocyclic double bond with analgesic effects
SE9604786D0 (sv)	1996-12-20	1996-12-20	Astra Pharma Inc	New compounds
JP4754068B2 (ja)	1997-12-24	2011-08-24	オーソ−マクニール・フアーマシユーチカル・インコーポレーテツド	δ−オピオイドレセプターに結合する４−［アリール（ピペリジン−４−イル）］アミノベンズアミド類
SE9904673D0 (sv)	1999-12-20	1999-12-20	Astra Pharma Inc	Novel compounds
SE9904675D0 (sv)	1999-12-20	1999-12-20	Astra Pharma Inc	Novel compounds
SE9904674D0 (sv)	1999-12-20	1999-12-20	Astra Pharma Inc	Novel compounds
SE0001209D0 (sv)	2000-04-04	2000-04-04	Astrazeneca Canada Inc	Novel compounds
SE0101765D0 (sv)	2001-05-18	2001-05-18	Astrazeneca Ab	Novel compounds
SE0101766D0 (sv)	2001-05-18	2001-05-18	Astrazeneca Ab	Novel compounds
AR035974A1 (es)	2001-05-18	2004-07-28	Astrazeneca Ab	Derivados de diarilmetil piperazina, procesos para su preparacion, uso de estos derivados para la elaboracion de medicamentos y composicion farmaceutica
SE0103313D0 (sv)	2001-10-03	2001-10-03	Astrazeneca Ab	Novel compounds
JP4892654B2 (ja) *	2001-10-29	2012-03-07	マウントクックファーマ，インコーポレーテッド	デルタレセプターアゴニスト化合物によるうつ病の治療方法
US8476280B2 (en)	2002-05-09	2013-07-02	Versi Group, Llc	Compositions and methods for combating lower urinary tract dysfunctions with delta opioid receptor agonists
SE0203300D0 (sv)	2002-11-07	2002-11-07	Astrazeneca Ab	Novel Compounds
SE0203303D0 (sv)	2002-11-07	2002-11-07	Astrazeneca Ab	Novel Compounds
SE0203302D0 (sv)	2002-11-07	2002-11-07	Astrazeneca Ab	Novel Compounds
SE0300105D0 (sv)	2003-01-16	2003-01-16	Astrazeneca Ab	Diarylmethylidene piperdine derivatives, preparations thereof and uses thereof
SE0400027D0 (sv)	2004-01-09	2004-01-09	Astrazeneca Ab	Diarylmethyl piperazine derivatives, preparations thereof and uses thereof
SE0401968D0 (sv)	2004-08-02	2004-08-02	Astrazeneca Ab	Diarylmethyl piperazine derivatives, preparations thereof and uses thereof
US20080262229A1 (en)	2005-02-28	2008-10-23	Astrazeneca Ab	Diarylmethyl Piperazine Derivatives, Preparations Thereof and Uses Thereof

2002
- 2002-11-07 SE SE0203300A patent/SE0203300D0/xx unknown
2003
- 2003-05-11 UA UAA200503861A patent/UA79824C2/uk unknown
- 2003-11-04 TW TW092130855A patent/TW200418823A/zh unknown
- 2003-11-05 AU AU2003274884A patent/AU2003274884B2/en not_active Ceased
- 2003-11-05 MX MXPA05004709A patent/MXPA05004709A/es active IP Right Grant
- 2003-11-05 CN CNB2003801028254A patent/CN100471844C/zh not_active Expired - Fee Related
- 2003-11-05 PL PL376895A patent/PL376895A1/pl not_active Application Discontinuation
- 2003-11-05 KR KR1020057008068A patent/KR20050072794A/ko not_active Ceased
- 2003-11-05 US US10/533,744 patent/US7396834B2/en not_active Expired - Fee Related
- 2003-11-05 WO PCT/SE2003/001703 patent/WO2004041800A1/en not_active Ceased
- 2003-11-05 BR BR0315998-1A patent/BR0315998A/pt not_active IP Right Cessation
- 2003-11-05 CA CA002502733A patent/CA2502733A1/en not_active Abandoned
- 2003-11-05 AR ARP030104056A patent/AR041898A1/es unknown
- 2003-11-05 NZ NZ539483A patent/NZ539483A/en unknown
- 2003-11-05 RU RU2005111983/04A patent/RU2326875C2/ru not_active IP Right Cessation
- 2003-11-05 EP EP03759164A patent/EP1562922A1/en not_active Withdrawn
- 2003-11-05 JP JP2004549772A patent/JP2006507296A/ja not_active Abandoned
2005
- 2005-05-04 ZA ZA200503553A patent/ZA200503553B/en unknown
- 2005-05-25 IS IS7864A patent/IS7864A/is unknown
- 2005-06-06 NO NO20052699A patent/NO20052699L/no not_active Application Discontinuation

Also Published As

Publication number	Publication date
MXPA05004709A (es)	2005-08-03
US20060167004A1 (en)	2006-07-27
AU2003274884A1 (en)	2004-06-07
KR20050072794A (ko)	2005-07-12
RU2005111983A (ru)	2006-01-20
US7396834B2 (en)	2008-07-08
BR0315998A (pt)	2005-09-20
CA2502733A1 (en)	2004-05-21
NZ539483A (en)	2007-12-21
WO2004041800A1 (en)	2004-05-21
EP1562922A1 (en)	2005-08-17
UA79824C2 (en)	2007-07-25
PL376895A1 (pl)	2006-01-09
ZA200503553B (en)	2006-09-27
SE0203300D0 (sv)	2002-11-07
AU2003274884B2 (en)	2007-11-15
RU2326875C2 (ru)	2008-06-20
TW200418823A (en)	2004-10-01
CN100471844C (zh)	2009-03-25
NO20052699L (no)	2005-06-06
IS7864A (is)	2005-05-25
CN1711251A (zh)	2005-12-21
AR041898A1 (es)	2005-06-01
JP2006507296A (ja)	2006-03-02

Publication	Publication Date	Title
NO20022680L (no)	2002-08-12	Farmasoytiske kombinasjoner og deres anvendelse ved behandling av gastrointestinale forstyrrelser
IS7032A (is)	2003-11-13	4(fenýl-píperasinýl-metýl)bensamíðafleiður og notkun þeirra til meðhöndlunar á sársauka, kvíða eða truflunum í maga og þörmum
NO20043370L (no)	2004-09-28	N-pyrazinylfenylsulfonamider og deres anvendelse ved behandling av kemokinmedierte sykdommer
IS7203A (is)	2004-03-31	4[píperidín-4-ýliden-(3-karbamólýlfenýl)metýl]bensamíðafleiður og notkun þeirra til að meðhöndla verki, mænuskaða eða maga- og garnasjúkdóma
NO20052698D0 (no)	2005-06-06	4(fenylpiperazinyl-metyl)benzamid-derivater og deres anvendelse ved behandling av smerte og gasatrintestinale lidelser.
IS6966A (is)	2003-09-24	Cýanó-tengd díhýdrópýrimídín efnasambönd og notkun þeirra við meðhöndlun sjúkdóma
NO20052699D0 (no)	2005-06-06	4(fenylpiperazinyl-metyl)benzamid-derivater og deres anvendelse ved behandling av smerte og gastrointestinale lidelser.
IS7026A (is)	2003-11-11	4-(fenýl-píperidín-4-ýlíden-metýl)-bensamíðafleiður og notkun þeirra til meðhöndlunar á sársauka, kvíða eða truflunum í maga og þörmum
IS6967A (is)	2003-09-24	Ný cýanó-tengd díhýdrópýrimídín efnasambönd og notkun þeirra við meðhöndlun sjúkdóma
EE200300527A (et)	2004-02-16	4-(fenüülpiperidiin-4-ülideenmetüül)bensamiidi derivaadid ja nende kasutamine valu, ärevuse või seedetrakti häirete raviks
NO20040659L (no)	2004-02-13	Isoksazolopyridinoner og andvendelse derav ved behandling av Parkinsons sykdom
AU2003278664A1 (en)	2004-06-07	4(phenyl-piperazinyl-methyl) benzamide derivatives and their use for the treatment of pain or gastrointestinal disorders
IS7025A (is)	2003-11-11	4-(fenýl-píperidín-4-ýlíden-metýl)-bensamíðafleiður og notkun þeirra til meðhöndlunar á sársauka, kvíða eða truflunum í maga og þörmum
IS7024A (is)	2003-11-11	4-(fenýl-píperidín-4-ýlíden-metýl)-bensamíðafleiður og notkun þeirra til meðhöndlunar á sársauka, kvíða eða truflunum í maga og þörmum
NO20035113D0 (no)	2003-11-17	4-(fenyl-(piperidin-4-yl)-amino)-benzamidderivater og deres anvendelse vedbehandling av angst, smerte eller gastrointestinale forstyrrelser
NO20035114D0 (no)	2003-11-17	4-(fenyl-(piperidin-4-yl)-amino)-benzamidderivater og deres anvendelse vedbehandling av angst, smerte eller gastrointestinale forstyrrelser
NO20035112D0 (no)	2003-11-17	4-(fenyl-(piperidin-4-yl)-amino)-benzamidderivater og deres anvendelse vedbehandling av smerte, angst eller gastrointestinale forstyrrelser
NO20035119D0 (no)	2003-11-17	4-(fenyl-(piperidin-4-yl)-amino)-benzamidderivater og deres anvendelse vedbehandling av angst, smerte eller gastrointestinale forstyrrelser
HK1079516A (en)	2006-04-07	4(phenyl-piperazinyl-methyl) benzamide derivatives and their use for the treatment of pain or gastrointestinal disorders
HK1079515A (en)	2006-04-07	4(phenyl-piperazinyl-methyl) benzamide derivatives and their use for the treatment of pain or gastrointestinal disorders

Legal Events

Date	Code	Title	Description
2010-06-28	FC2A	Withdrawal, rejection or dismissal of laid open patent application